ERYTECH Pharma S.A. (ERYP) Business Metric Overview - Stocknear

ERYTECH Pharma S.A.

NASDAQ: ERYP · Real-Time Price · USD
0.78
0.01 (1.30%)
At close: Jun 28, 2023, 9:48 PM

Revenue by Geography

Period Ending Jun 30, 2022 Jun 30, 2021
France Revenue n/a n/a
France Revenue Growth n/a n/a
United States Revenue 54K 97K
United States Revenue Growth -44.33% n/a

Operating Expense Breakdown

Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Selling, General, and Administrative Revenue 3.02M 3.79M 2.14M 4.94M 2.86M 4.55M 3.52M 4.17M 2.84M 3.42M 4.19M 4.49M 3.26M 3.52M 4.79M 4.85M 4.47M 3.08M
Selling, General, and Administrative Revenue Growth -20.50% +77.59% -56.72% +72.72% -37.14% +29.17% -15.62% +47.14% -16.98% -18.39% -6.73% +37.67% -7.31% -26.59% -1.16% +8.41% +45.35% n/a
Research and Development Revenue -470K 3.08M 9.18M 8.12M 10.37M 11.52M n/a n/a n/a n/a 14.42M 15.35M -34.64M n/a n/a 9.17M n/a n/a
Research and Development Revenue Growth -115.27% -66.50% +13.16% -21.75% -9.96% n/a n/a n/a n/a -100.00% -6.04% -144.32% n/a n/a -100.00% n/a n/a n/a